Collagen for bone health
20 Feb 2020 | Rousselot
At FiE 2019 in Paris, Rousselot was highlighting its brand Peptan and the new clinical backing that the range has received. A study found that collagen has a positive impact on bone health, marking a strong stride for the company, especially as the trial used methodology very close to a human trial. Frank Engel, Global Market Development Manager at Peptan, emphasizes how important it is to have clinical backing in such a saturated market.
